Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Award Notice

Influenza Vaccines

  • First published: 15 April 2019
  • Last modified: 15 April 2019
  • Version: N/A
  •  

  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
Published by:
The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’)
Authority ID:
AA20671
Publication date:
15 April 2019
Deadline date:
-
Notice type:
Contract Award Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

This procurement is for the supply of adjuvanted trivalent influenza vaccine (Fluad) for use in the annual seasonal influenza immunisation programme in General Practices and Hospitals across NHS Scotland.

Full notice text

Contract award notice

Results of the procurement procedure

Section I: Contracting entity

I.1) Name and addresses

The Common Services Agency (more commonly known as NHS National Services Scotland) (“NSS")

Gyle Square (NSS Head Office), 1 South Gyle Crescent

Edinburgh

EH12 9EB

UK

Contact person: Laura Ferguson

Telephone: +44 1312756725

E-mail: lauraferguson1@nhs.net

NUTS: UKM

Internet address(es)

Main address: http://www.nhsscotlandprocurement.scot.nhs.uk/

Address of the buyer profile: https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883

I.2) Joint procurement

The contract is awarded by a central purchasing body

I.4) Type of the contracting authority

Regional or local authority

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Influenza Vaccines

Reference number: NP93819

II.1.2) Main CPV code

33651660

 

II.1.3) Type of contract

Supplies

II.1.4) Short description

This procurement is for the supply of adjuvanted trivalent influenza vaccine (Fluad) and cell-culture based quadrivalent influenza vaccine (Flucelvax) to NHS Scotland for use in the annual seasonal influenza immunisation programme in general practices and Hospitals across NHS Scotland.

II.1.6) Information about lots

This contract is divided into lots: Yes

II.1.7) Total value of the procurement

Value excluding VAT: 6 248 000.00  GBP

II.2) Description

Lot No: 1

II.2.1) Title

NP93819a Fluad

II.2.2) Additional CPV code(s)

33651660

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Delivery should be made to OM Movianto, Unit 1, Haydock Green, Penny Lane, Haydock, WA11 9DT

II.2.4) Description of the procurement

This procurement is for the supply of adjuvanted trivalent influenza vaccine (Fluad) for use in the annual seasonal influenza immunisation programme in General Practices and Hospitals across NHS Scotland.

II.2.5) Award criteria

Price

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 2

II.2.1) Title

NP93819b Flucelvax

II.2.2) Additional CPV code(s)

33651660

II.2.3) Place of performance

NUTS code:

UK


Main site or place of performance:

Delivery should be made to OM Movianto, Unit 1, Haydock Green, Penny Lane, Haydock, WA11 9DT

II.2.4) Description of the procurement

This procurement is for the supply of cell-culture based quadrivalent influenza vaccine (Flucelvax) for use in the annual seasonal influenza immunisation programme in General Practices and Hospitals across NHS Scotland.

II.2.5) Award criteria

Price

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Award of a contract without prior publication of a call for competition

Justification for selected award procedure:

The works, supplies or services can be provided only by a particular economic operator for the following reason: protection of exclusive rights, including intellectual property rights

Explanation

Seqirus UK Ltd are currently the sole supplier of adjuvanted trivalent, and cell-culture based quadrivalent, influenza vaccines for which no direct competition exists.

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information

IV.2.1) Previous publication concerning this procedure

Notice number in the OJ S:

2019/S 053-121938

Section V: Award of contract

Lot No: 1

Title: NP93819a Fluad

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

01/04/2019

V.2.2) Information about tenders

Number of tenders received: 1

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Seqirus UK Ltd

Gaskill Road, Speke

Liverpool

L24 9GR

UK

Telephone: +44 1517055677

NUTS: UKD72

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 3 399 000.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 2

Title: NP93819b Flucelvax

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

01/04/2019

V.2.2) Information about tenders

Number of tenders received: 1

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Seqirus UK Ltd

Gaskill Road, Speke

Liverpool

L24 9GR

UK

Telephone: +44 1517055677

NUTS: UKD72

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 2 849 000.00  GBP

V.2.5) Information about subcontracting

Section VI: Complementary information

VI.3) Additional information

The total value in Section II.1.7 and V.2.4 refers to the twelve (12) month duration of the contract.

(SC Ref:578003)

VI.4) Procedures for review

VI.4.1) Review body

The Common Services Agency (more commonly known as NHS National Services Scotland) (“NSS”)

Gyle Square (NSS Head Office), 1 South Gyle Crescent

Edinburgh

EH12 9EB

UK

Telephone: +44 1698794410

Internet address(es)

URL: http://www.nhsscotlandprocurement.scot.nhs.uk/

VI.4.3) Review procedure

Precise information on deadline(s) for review procedures:

The bringing of court proceedings against the Authority after the contract has been entered into will not affect the contract unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the contract has been entered into are limited to the award of damages.

VI.5) Date of dispatch of this notice

11/04/2019

Coding

Commodity categories

ID Title Parent category
33651660 Influenza vaccines General anti-infectives for systemic use and vaccines

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
lauraferguson1@nhs.net
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.